OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Rini on the Mechanism of Action of Tivozanib in Relapsed/Refractory RCC

April 26th 2021

Brian I. Rini, MD, discusses the mechanism of action of tivozanib in relapsed/refractory renal cell carcinoma.

Dr. Usmani on the Potential Future of Isatuximab in Multiple Myeloma

April 26th 2021

Saad Z. Usmani, MD, FACP, discusses the potential future utility of isatuximab-irfc in multiple myeloma.

Dr. Raz on the Effects of COVID-19 on Lung Cancer Screening

April 26th 2021

Dan J. Raz, MAS, MD, discusses the effects of COVID-19 on lung cancer screening.

Dr. Choudhury on Future Research Directions for Pembrolizumab/Radium-223 in mCRPC

April 26th 2021

Atish D. Choudhury, MD, PhD, discusses future research directions for the combination of pembrolizumab and radium-223 dichloride in patients with metastatic castration-resistant prostate cancer.

Dr. Shadman on the Emergence of Third-Generation BTK Inhibitors in CLL

April 23rd 2021

Mazyar Shadman, MD, discusses the emergence of third-generation BTK inhibitors in chronic lymphocytic leukemia.

Dr. Ward on Considerations for Salvage Radiation Therapy in Prostate Cancer

April 23rd 2021

Matthew C. Ward, MD, discusses considerations for salvage radiation therapy in prostate cancer.

Dr. Shah on Future Directions With CAR T-Cell Therapy in Multiple Myeloma

April 23rd 2021

Nina Shah, MD, discusses potential future directions with CAR T-cell therapy in multiple myeloma.

Dr. Tewari on Key Differences Between Racial Subgroups in Prostate Cancer

April 23rd 2021

Ashutosh K. Tewari, MD, discusses some of the key differences between racial subgroups in prostate cancer.

Dr. Hahn on Future Research Directions with Tucatinib in Breast Cancer

April 23rd 2021

Olwen Hahn, MD, discusses future research directions with tucatinib (Tukysa) in the treatment of patients with breast cancer.

Dr. Tewari on the Hallmarks of Cancer in Black Men With Prostate Cancer

April 22nd 2021

Ashutosh K. Tewari, MD, discusses the hallmarks of cancer among Black men with prostate cancer.

Dr. Vij on the Integration of Selinexor in Relapsed/Refractory Multiple Myeloma

April 22nd 2021

Ravi Vij, MD, MBA, discusses the integration of selinexor into the relapsed/refractory multiple myeloma armamentarium.

Dr. Burgess on the FDA Accelerated Approval of Rucaparib in BRCA+ mCRPC

April 22nd 2021

Earle Burgess, MD, discusses the FDA accelerated approval of rucaparib in BRCA-positive metastatic castration-resistant prostate cancer.

Dr. Skarbnik on the Optimization of CAR T-Cell Therapy Sequencing in MCL

April 22nd 2021

Alan P. Z. Skarbnik, MD, discusses the optimization of treatment sequencing with CAR T-cell therapy in mantle cell lymphoma.

Dr. Tewari on the Potential Benefits of a Mobile MRI Unit in Prostate Cancer

April 21st 2021

Ashutosh K. Tewari, MD, director, Department of Urology, Mount Sinai, discusses the potential benefits of a mobile MRI unit in prostate cancer.

Dr. Au on the Results of a Subgroup Analysis Evaluating Antibody Response to COVID-19 in Cancer

April 21st 2021

Lewis Au, MBBS, BMedSci, FRACP, discusses the results of a subgroup analysis evaluating antibody responses to COVID-19 in patients with cancer.

Dr. Rapisuwon on Biologic Differences Between Mucosal and Cutaneous Melanoma

April 20th 2021

Suthee Rapisuwon, MD, discusses the biologic differences between mucosal and cutaneous melanoma.

Dr. Ward on the Debate Over Adjuvant Radiation Therapy in Prostate Cancer

April 20th 2021

Matthew C. Ward, MD, discusses the debate over adjuvant radiation therapy in prostate cancer.

Dr. Charlton on the Effects of the COVID-19 Pandemic on HCC

April 20th 2021

Michael R. Charlton, MD, MBBS, discusses the effects of the COVID-19 pandemic on hepatocellular carcinoma.

Dr. Barrientos on Treatment Considerations for CLL

April 20th 2021

Jacqueline Claudia Barrientos, MD, MS, discusses treatment considerations for patients with chronic lymphocytic leukemia.

Dr. Gradishar on Pretreatment With Cetirizine to Prevent Infusion Reactions in Breast Cancer and Other Malignancies

April 19th 2021

William Gradishar, MD, discusses the efficacy of pretreatment with intravenous cetirizine in the prevention of infusion reactions in patients with breast cancer and other malignancies.